Fund shareholders of Evolus Inc
ISIN US30052C1071 · United States · LEI 549300VYQRYBQOT8V419
- Fund shareholders
- 110
- Of which ETFs
- 18 92 other funds
- Value held
- ≈ 59.9M $ 59.8M $ · 89.6K €
- Share of capital
- 13.4 % of 66.1M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Russell 2000 Fund Rydex Series Funds | 147 | 1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 95 | 659.3 $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 88 | 610.7 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 52 | 341.1 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 50 | 292 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 37 | 216.1 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 118 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 16 | 105 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 56.6K € | 0.07 % | as of Dec 31, 2025 ↗ | ||
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 33K € | 0.25 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Corgi Beauty, Skincare & Aesthetics ETF Corgi ETF Trust I | 3.30 % | as of Jun 30, 2026 ↗ |
| FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND Capitol Series Trust | 0.92 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.53 % | as of Jun 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.51 % | as of Jun 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.33 % | as of Jul 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.31 % | as of Jul 31, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 0.25 % | as of Dec 31, 2025 ↗ |
| Clearwater Select Equity Fund Clearwater Investment Trust | 0.16 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.12 % | as of Jun 30, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 0.10 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 108 | +7 | 8,877,845 | +14.4 % |
| 2026Q2 | 101 | -8 | 7,760,944 | -4.4 % |
| 2026Q1 | 109 | -13 | 8,119,881 | -10.0 % |
| 2025Q4 | 122 | -11 | 9,018,046 | -6.8 % |
| 2025Q3 | 133 | -12 | 9,674,182 | -6.1 % |
| 2025Q2 | 145 | +11 | 10,297,747 | +7.7 % |
| 2025Q1 | 134 | +3 | 9,560,022 | +1.4 % |
| 2024Q4 | 131 | +8 | 9,428,903 | +19.8 % |
| 2024Q3 | 123 | -7 | 7,870,293 | +1.2 % |
| 2024Q2 | 130 | +18 | 7,774,645 | +2.8 % |
| 2024Q1 | 112 | -1 | 7,559,470 | -2.3 % |
| 2023Q4 | 113 | 7,737,517 |
Institutional managers
142 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Nantahala Capital Management, LLC | 6,376,857 | 26.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,290,383 | 17.6M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 3,105,209 | 12.8M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 2,630,665 | 10.8M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 2,245,360 | 9.2M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 1,759,091 | 7.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,461,159 | 6M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,396,000 | 5.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,381,338 | 5.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,320,790 | 5.4M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,286,862 | 5.3M $ | as of Mar 31, 2026 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,254,819 | 5.2M $ | as of Mar 31, 2026 |
| PINNACLE ASSOCIATES LTD | 1,158,895 | 4.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,086,398 | 4.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 752,881 | 3.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 696,629 | 2.9M $ | as of Mar 31, 2026 |
| Soviero Asset Management, LP | 680,373 | 2.8M $ | as of Mar 31, 2026 |
| AWH Capital, L.P. | 625,000 | 2.6M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 598,145 | 2.5M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 559,050 | 2.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 515,516 | 2.1M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 483,021 | 2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 472,343 | 1.9M $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 458,396 | 1.9M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 441,655 | 1.8M $ | as of Mar 31, 2026 |
Declared shareholders of Evolus Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Soleus Capital Master Fund, L.P. and 5 others | 5.30 % | 3,480,000 | as of Aug 27, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Evolus Inc". https://titelia.com/en/stocks/evolus-inc-US30052C1071